Hui CWC - Search Results

1

Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study.

Hui EP, Ma BBY, Loong HHF, Mo F, Li L, King AD, Wang K, Ahuja AT, Chan CML, Hui CWC, Wong CH, Chan ATC. Hui EP, et al. Among authors: hui cwc. Clin Cancer Res. 2018 Mar 1;24(5):1030-1037. doi: 10.1158/1078-0432.CCR-17-1667. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301831 Clinical Trial.

2

FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.

Lui VW, Yau DM, Cheung CS, Wong SC, Chan AK, Zhou Q, Wong EY, Lau CP, Lam EK, Hui EP, Hong B, Hui CW, Chan AS, Ng PK, Ng YK, Lo KW, Tsang CM, Tsui SK, Tsao SW, Chan AT. Lui VW, et al. Oncogene. 2011 Mar 31;30(13):1518-30. doi: 10.1038/onc.2010.529. Epub 2010 Nov 29. Oncogene. 2011. PMID: 21119603

3

Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.

Ma BB, Lui VW, Hui CW, Lau CP, Wong CH, Hui EP, Ng MH, Tsao SW, Li Y, Chan AT. Ma BB, et al. Invest New Drugs. 2013 Jun;31(3):567-75. doi: 10.1007/s10637-012-9896-5. Epub 2012 Nov 11. Invest New Drugs. 2013. PMID: 23143779

4

Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.

Chan SL, Wong CH, Lau CP, Zhou Q, Hui CW, Lui VW, Ma BB, Chan AT, Yeo W. Chan SL, et al. Cancer Chemother Pharmacol. 2013 Jun;71(6):1417-25. doi: 10.1007/s00280-013-2139-4. Epub 2013 Apr 2. Cancer Chemother Pharmacol. 2013. PMID: 23546591

5

Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma.

Wong CH, Loong HH, Hui CW, Lau CP, Hui EP, Ma BB, Chan AT. Wong CH, et al. Invest New Drugs. 2013 Dec;31(6):1399-408. doi: 10.1007/s10637-013-0007-z. Epub 2013 Aug 24. Invest New Drugs. 2013. PMID: 23975511

6

Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.

Ma BB, Lui VW, Hui CW, Lau CP, Wong CH, Hui EP, Ng MH, Cheng SH, Tsao SW, Tsang CM, Cheung CS, Ho K, Chan AT. Ma BB, et al. Cancer Lett. 2014 Feb 1;343(1):24-32. doi: 10.1016/j.canlet.2013.09.007. Epub 2013 Sep 14. Cancer Lett. 2014. PMID: 24041865

7

Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma.

Wong CH, Ma BBY, Hui CWC, Lo KW, Hui EP, Chan ATC. Wong CH, et al. Among authors: hui cwc. Sci Rep. 2018 May 22;8(1):8010. doi: 10.1038/s41598-018-26201-1. Sci Rep. 2018. PMID: 29789630 Free PMC article.

8

Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models.

Lam RCT, Hui CWC, Wong CH, Lo KW, Tsang ACM, Hui EP, Chan ATC, Ma BBY. Lam RCT, et al. Among authors: hui cwc. Invest New Drugs. 2023 Oct;41(5):699-709. doi: 10.1007/s10637-023-01384-1. Epub 2023 Aug 12. Invest New Drugs. 2023. PMID: 37572231

9

Synergistic activities of Panobinostat and doxorubicin in soft tissue sarcomas.

Zhang Y, Wong CH, Hui CWC, Tse T, Yeung V, Cheung K, Tao Q, Loong HH. Zhang Y, et al. Among authors: hui cwc. Biomed Pharmacother. 2024 Jul;176:116895. doi: 10.1016/j.biopha.2024.116895. Epub 2024 Jun 14. Biomed Pharmacother. 2024. PMID: 38876055 Free article.

10

Total flavones of Hippophae rhamnoides promotes early restoration of ultimate stress of healing patellar tendon in a rat model.

Fu SC, Hui CW, Li LC, Cheuk YC, Qin L, Gao J, Chan KM. Fu SC, et al. Med Eng Phys. 2005 May;27(4):313-21. doi: 10.1016/j.medengphy.2004.12.011. Med Eng Phys. 2005. PMID: 15823472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters